Cancer Multi-Omics Analysis Service

Cancer multi-omics analysis is a comprehensive approach that integrates multiple omics data—including genomics, transcriptomics, epigenomics, proteomics, and metabolomics—to fully understand the mechanisms underlying cancer development, progression, and metastasis. Given the complexity of cancer, single-omics studies often fail to provide a complete molecular picture. Multi-omics integration enables researchers to investigate cancer from various levels, including gene mutations, gene expression, protein modifications, and metabolic changes, allowing for the construction of a robust regulatory network.

 

MtoZ Biolabs offers a comprehensive Cancer Multi-Omics Analysis Service, leveraging advanced technologies across genomics, transcriptomics, proteomics, phosphoproteomics, and DNA methylation analysis. By integrating these multi-level datasets, we can precisely differentiate cancer molecular subtypes, uncover the underlying mechanisms of oncogenesis, and identify potential diagnostic and therapeutic targets. This robust data support accelerates the development of cancer-targeted therapies and personalized treatment strategies.

 

Analysis Workflow

 



Momeni, Z. et al. J Biomed Inform. 2020.

 

Service Advantages

1. Comprehensive Omics Integration

Provides a full-spectrum analysis of cancer molecular mechanisms by integrating data from genomics, transcriptomics, epigenomics, proteomics, and metabolomics.

 

2. Precision Target Identification

Cross-validation across omics layers ensures accurate identification of clinically relevant targets for drug development.

 

3. Cancer Subtype Classification

Integrated multi-omics analysis enables precise differentiation of cancer subtypes, supporting personalized treatment decisions.

 

4. High Data Reliability

High-resolution data from sequencing and mass spectrometry enhance sensitivity, enabling the detection of low-abundance molecules relevant to cancer.

 

5. Expert Support

Our experienced scientific team provides comprehensive support throughout the experimental design and data analysis phases.

 

Applications

1. Molecular Subtype Identification: Classify cancer molecular subtypes based on integrated multi-omics data, supporting precision medicine and tailored therapies.

2. Oncogenesis Research: Explore cancer initiation, progression, and metastasis mechanisms through genomic, transcriptomic, and proteomic integration, identifying key oncogenic drivers.

3. Targeted Drug Development: Identify clinically relevant targets through multi-omics data, facilitating the development of personalized treatments for cancer patients.

4. Biomarker Discovery: Discover diagnostic, prognostic, and treatment-response biomarkers by combining omics and clinical data.

5. Drug Resistance Mechanism Research: Investigate cancer drug resistance mechanisms using multi-omics data, uncovering potential therapeutic strategies to overcome resistance.

6. Metabolic Pathway Research: Analyze metabolic disruptions in cancer through metabolomics, identifying potential targets for metabolic interventions.

 

Deliverables

What Could be Included in the Report?

1. Comprehensive Experimental details

2. Materials, Instruments, and Methods

3. Total Ion Chromatogram & Quality Control Assessment (project-dependent)

4. Data Analysis, Preprocessing, and Estimation (project-dependent)

5. Bioinformatics Analysis

6. Raw Data Files

 

MtoZ Biolabs, an integrated Chromatography and Mass Spectrometry (MS) Services Provider, provides advanced proteomics, metabolomics, and multi-omics analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. Our ultimate aim is to provide more rapid, high-throughput, and cost-effective analysis, with exceptional data quality and minimal sample consumption. For any inquiries or requirements, please contact us.